Literature DB >> 8449182

Analysis of electrocardiographic changes in status epilepticus.

J G Boggs1, J A Painter, R J DeLorenzo.   

Abstract

The high mortality associated with status epilepticus (SE) has been hypothesized to result partially from neurologically induced changes in cardiac function. To test this hypothesis, we reviewed electrocardiograms of 60 patients presenting in status epilepticus. Sequential electrocardiograms before, during and after ictal episodes were compared to define changes from baseline studies. 58.3% of the SE patients (N = 35) exhibited significant abnormalities on electrocardiograms obtained within 24 h of status epilepticus. Specific electrocardiographic changes included arrhythmias, axis changes, conduction abnormalities and ischemic patterns. All of these abnormal ECG changes met generally accepted cardiologic standards for a high risk of myocardial dysfunction or ischemia. The association of ECG changes with mortality was statistically significant. These results indicate that a significant proportion of SE patients are at risk for cardiac dysfunction and that close monitoring of cardiac function is indicated during and after SE.

Entities:  

Mesh:

Year:  1993        PMID: 8449182     DOI: 10.1016/0920-1211(93)90077-k

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  13 in total

1.  Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis.

Authors:  Jason McMullan; Comilla Sasson; Arthur Pancioli; Robert Silbergleit
Journal:  Acad Emerg Med       Date:  2010-06       Impact factor: 3.451

Review 2.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 3.  [Emergency and intensive medical care of status epilepticus].

Authors:  A C Hoppner; W Klingler
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04       Impact factor: 0.840

4.  Autonomic and cellular mechanisms mediating detrimental cardiac effects of status epilepticus.

Authors:  Steven L Bealer; Jason G Little; Cameron S Metcalf; Amy L Brewster; Anne E Anderson
Journal:  Epilepsy Res       Date:  2010-07-21       Impact factor: 3.045

Review 5.  [Refractory status epilepticus: diagnosis, therapy, course, and prognosis].

Authors:  F Bösebeck; G Möddel; K Anneken; M Fischera; S Evers; E B Ringelstein; C Kellinghaus
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

6.  Methods for ECG evaluation of indicators of cardiac risk, and susceptibility to aconitine-induced arrhythmias in rats following status epilepticus.

Authors:  Steven L Bealer; Cameron S Metcalf; Jason G Little
Journal:  J Vis Exp       Date:  2011-04-05       Impact factor: 1.355

Review 7.  Generalised convulsive status epilepticus: an overview.

Authors:  R Nandhagopal
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

8.  Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus.

Authors:  M I Read; J C Harrison; D S Kerr; I A Sammut
Journal:  Br J Pharmacol       Date:  2015-08-24       Impact factor: 8.739

9.  Intramuscular atenolol and levetiracetam reduce mortality in a rat model of paraoxon-induced status epilepticus.

Authors:  Laxmikant S Deshpande; Robert E Blair; Matthew Halquist; Leon Kosmider; Robert J DeLorenzo
Journal:  Ann N Y Acad Sci       Date:  2020-09-22       Impact factor: 5.691

Review 10.  Clinical review: status epilepticus.

Authors:  Sarice Bassin; Teresa L Smith; Thomas P Bleck
Journal:  Crit Care       Date:  2002-03-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.